Provided by Tiger Fintech (Singapore) Pte. Ltd.

Denali Therapeutics Inc.

14.90
+0.95006.81%
Post-market: 14.89-0.0100-0.07%19:10 EDT
Volume:1.71M
Turnover:25.12M
Market Cap:2.16B
PE:-5.58
High:15.00
Open:14.06
Low:13.94
Close:13.95
Loading ...

BRIEF-Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted To Tividenofusp Alfa For The Treatment Of Hunter Syndrome (MPS II)

Reuters
·
08 Jan

Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (Mps Ii)

THOMSON REUTERS
·
08 Jan

Denali Therapeutics Inc - Expects to Submit Bla for Tividenofusp Alfa in Early 2025

THOMSON REUTERS
·
08 Jan

Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)

GlobeNewswire
·
08 Jan

Denali Therapeutics price target lowered to $32 from $35 at BTIG

TipRanks
·
08 Jan

Denali's ALS Study Fails to Meet Primary and Secondary Endpoints

Zacks
·
08 Jan

Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected

Benzinga
·
08 Jan

Denali recent pullback a buying opportunity, says Jefferies

TIPRANKS
·
07 Jan

Baird Initiates Denali Therapeutics at Outperform With $31 Price Target

MT Newswires Live
·
07 Jan

BUZZ-Denali Therapeutics falls after ALS drug fails in mid-to-late stage trial

Reuters
·
07 Jan

Denali Therapeutics Shares Down 8.3% Premarket After Co's ALS Drug Fails in Mid-to-Late Stage Trial

THOMSON REUTERS
·
07 Jan

U.S. Stocks to Watch: Nvidia, Micron, Uber, FuboTV, Aurora Innovation, Plug Power, Inari Medical, and More

Dow Jones
·
07 Jan

BTIG Keeps Their Buy Rating on Denali Therapeutics (DNLI)

TIPRANKS
·
07 Jan

Denali Therapeutics Initiated at Outperform by Baird

Dow Jones
·
07 Jan

U.S. RESEARCH ROUNDUP-CNX Resources, Inari Medical, Royal Gold

Reuters
·
07 Jan

Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Denali Therapeutics (DNLI) and Inspire Medical Systems (INSP)

TIPRANKS
·
07 Jan

Denali Therapeutics Inc : JP Morgan Cuts Target Price to $24 From $28

THOMSON REUTERS
·
07 Jan

Stifel likes Denali Therapeutics on weakness

TIPRANKS
·
07 Jan

Denali Therapeutics Shares Down 6.2% After the Bell; Denali Therapeutics ALS Drug Fails in Mid-Stage Trial

THOMSON REUTERS
·
07 Jan

Denali Therapeutics Trial of Potential ALS Treatment Misses Primary, Secondary Endpoints; Shares Fall After Hours

MT Newswires Live
·
07 Jan